Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Assets (2016 - 2025)

Historic Return on Assets for Ani Pharmaceuticals (ANIP) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Ani Pharmaceuticals' Return on Assets rose 400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.02% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Return on Assets of 0.03% as of Q3 2025, which was up 400.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Return on Assets ranged from a high of 0.04% in Q1 2024 and a low of 0.09% during Q3 2022
  • Moreover, its 5-year median value for Return on Assets was 0.02% (2025), whereas its average is 0.02%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 1100bps in 2023, then tumbled by -600bps in 2025.
  • Ani Pharmaceuticals' Return on Assets (Quarter) stood at 0.07% in 2021, then increased by 7bps to 0.06% in 2022, then soared by 133bps to 0.02% in 2023, then tumbled by -169bps to 0.01% in 2024, then soared by 304bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.01% for Q2 2025, and 0.02% during Q1 2025.